探索SEPSIS后和COVID-19后综合征:从病理生理学到治疗方法的交叉
Darcy Holmes1, Marta Colaneri2, Emanuele Palomba2
1Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Frontiers in medicine
|January 22, 2024
概括
败血症幸存者,包括COVID-19患者,可能会患上败血症后综合征 (PSS) 或PASC,导致多器官功能障碍. 向氨酸-血管素系统 (RAS) 为这些复杂的疾病提供了潜在的治疗途径.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 关键护理医学 关键护理医学
背景情况:
- 败血症,包括COVID-19,可以导致后败血症综合征 (PSS) 和COVID-19 (PASC) 的后急性后续.
- 这些情况具有相似之处,呈现出持续的多器官功能障碍 (呼吸道,心血管,脏,神经系统) 和失调的免疫反应 (免疫抑制,高炎症).
- 缺乏明确的定义和诊断标准阻碍了有效的治疗策略,强调了需要统一的治疗方法.
研究的目的:
- 探索PSS和PASC之间共同的临床和病理生理学相似之处.
- 确定潜在的治疗点,重点关注氨酸 - 血管新生素系统 (RAS).
- 强调需要采用多方面的方法,并进一步研究有效的治疗策略.
主要方法:
- 审查关于败血症,PSS,PASC和氨酸-血管新生系统的现有文献.
- 分析共享的免疫机制和病理生理路径.
- 识别针对RAS的潜在干预措施,如ACE抑制剂,ACE受体抑制剂和复合人类ACE2 (rhACE2).
主要成果:
- PSS和PASC表现出显著的临床和病理生理重叠,其特点是多器官功能障碍和免疫失调.
- 氨酸-血管素系统 (RAS) 在免疫调节中起着至关重要的作用,其不平衡可能会使这些情况恶化.
- 鉴定出ACE抑制剂,ACE受体抑制剂和rhACE2作为潜在的RAS向干预措施.
结论:
- 对于PSS和PASC,需要一个统一的治疗策略,解决共享的免疫机制和RAS参与.
- 进一步的研究,定义的标准化,增加资金和临床试验对于推进治疗至关重要.
- 准RAS是一个有前途的途径,用于管理败血症和COVID-19的复杂后果.
相关概念视频
Pneumonia II: Pathophysiology
278
The pathophysiology of pneumonia involves the following steps:
278
COPD: Pathogenesis and Clinical Features
275
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
275
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Pneumonia III: Complications and Assessment
227
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
227
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Acute Pancreatitis II: Clinical Manifestations and Management
125
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
125


